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The expression kinetics of an essential trans-regulatory protein, ICP27, from herpes simplex virus type 1 correspond to that
of an immediate-early gene whose expression increases rapidly upon infection and then decreases as of 7 hr postinfection. In
contrast, here we report that the bovine herpesvirus type 1 (BHV-1) homolog BICP27, a 50-kDa protein, is expressed as an
early gene. Both the transcript and protein accumulated gradually reaching peak levels at approximately 12 hr postinfection,
after which point steady state levels were maintained up to 24 hr. Thus the expression profiles of ICP27 and BICP27 are
significantly different, suggesting that they may possess different functions. q 1996 Academic Press, Inc.
Bovine herpesvirus 1 (BHV-1), a member of the Alpha- BHV-1 and HSV-1 proteins have similar functions. The
1200-bp-long BICP27 ORF was located within the HpaIherpesvirinæ, is an economically important pathogen of
cattle. BHV-1 is primarily associated with two major clini- G restriction fragment of the BHV-1 genome (Fig. 1A),
and its corresponding amino acid sequence showed 61cal syndromes of cattle, namely infectious bovine rhino-
tracheitis (IBR) and infectious pustular vulvovaginitis (IPV; and 69% similarity with that of HSV-1 ICP27 and equine
herpesvirus type 1 UL3 counterparts, respectively (10).1, 2). The BHV-1 genome, a 136-kbp linear double-
stranded DNA molecule, is composed of a long (UL) and A 1224-bp HinfI– HincII DNA fragment, representing the
complete ORF (Fig. 1A), specifically hybridized to a tran-a short (US) unique segment, the latter being flanked by
inverted repeat sequences (3). Two isomeric forms of the script of 1.7 kb on Northern blots containing total RNA
(Fig. 1B) isolated at different times post BHV-1 infectiongenome occur naturally as the US region has the ability
of inverting its orientation (4, 5). The viral DNA is believed of MDBK cells. Longer exposure of the blots (not shown)
revealed the presence of a minor band of 3.0 kb, whichto encode at least 70 polypeptides of which 25–33 are
structural components of the virion (6). It also encodes most probably represents a 3* coterminal transcript from
transcriptional regulatory proteins and enzymes involved the adjacent gene (10). The BICP27 1.7-kb-specific tran-
in DNA metabolism (7). script was detected at 3 hr postinfection (p.i.; lane 3), its
An international collaboration coordinated by Dr. abundance increased sixfold 12 hr p.i. (lane 12), and then
Schwyzer (Switzerland) was undertaken to complete the slightly decreased at 20 hr p.i. (lane 20). A similar profile
sequencing of the BHV-1 genome (7). This allowed the was observed with a blot representing poly(A)/ RNA ex-
identification of numerous open reading frames (ORFs) tracted at 6, 12, 18, and 24 hr p.i. (data not shown); this
corresponding to previously identified proteins of herpes blot permitted us to ascertain that the BICP27 message
simplex virus type 1 (HSV-1). Among these the homolog was still present at 24 hr p.i. The expression profile ob-
BICP27 of HSV-1-infected cell polypeptide 27 (ICP27), an served represents that of a gene whose expression is
essential immediate-early protein (8, 9) was identified. early following BHV-1 infection. Our results are consis-
We investigated the transcriptional and translational ex- tent with those of a previous study investigating the spa-
pression kinetics of BICP27 in order to obtain preliminary tial and temporal distribution of BHV-1 transcripts and
evidence permitting us to postulate as to whether the where an early transcript of 1.7 kb originating from the
HindIII fragment N of the viral genome was identified
(11). Interestingly, the size and kinetic class of the BICP27
1 Present address: Eastern Virginia Medical School, Department of transcript are similar to those of the transcript from the
Microbiology and Immunology, P.O. Box 1980, Norfolk, Virginia 23501.
EHV-1 homologous gene (UL3; 12).Fax: (804) 624-2255.
To analyze the expression kinetics of the BICP27 pro-2 To whom correspondence and reprint requests should be ad-
dressed. Fax: (514) 686-5626. E-mail: Claire_Simard@IAF.UQUEBEC.CA. tein in BHV-1-infected cells, we set out to generate a
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FIG. 1. Transcriptional kinetics of BICP27. (A) Schematic representations of the HindIII and HpaI restriction maps of the BHV-1 genome
illustrating an expanded view of the HpaI G fragment which includes the BICP27 ORF initiating at position 2860 and ending at base 1660. To
generate pKS/Ghp, purified BHV-1 DNA (IBR-like isolate 34; 23) was digested with HpaI, treated with 2 U of S1 nuclease (24) and fractionated
by agarose gel electrophoresis. The 3.1-kbp fragment was then purified and ligated to the EcoRV cloning site of the pKS Bluescript vector
(Stratagene) generating pKS/Ghp. Recombinants were identified by hybridization to the HindIII fragment N of the viral genome. (B) Expression
kinetics of the BICP27 transcript. A Northern blot of total RNA extracted from BHV-1-infected cells collected at different hours postinfection
(as indicated at the top of the autoradiogram) was performed as previously described (25). The blot was hybridized with a 1224-bp HinfI/
HincII-labeled fragment generated from pKS/Ghp and representing the complete BICP27 coding sequence. The numbers to the left correspond
to molecular weight sizes in kb. At the bottom of the autoradiogram is indicated the relative abundance of the 1.7-kb transcript. This was
evaluated by scanning the autoradiogram using the scanner ScanJet IICX (Hewlett-Packard), and then by analyzing the digitalized data using
the Jandel Video Analysis Software (Jadel Scientific, CA).
BICP27-specific antiserum. For this purpose the com- and HincII generating a 1244-bp fragment which was
ligated to the filled in SalI and cohesive BamHI ends ofplete BICP27 protein was expressed in Escherichia coli
using the pET21b translation vector (Novagen, Inc.) to pET21b. The resulting recombinant plasmid, pET/
BICP27, thus contains the complete BICP27 coding se-serve as an antigen. To generate the recombinant vector
pET/BICP27, a 1396-bp HinfI fragment encoding BICP27 quence in addition to four codons upstream of the ATG
fused in frame to the T7-Tag region. To ascertain properwas isolated from pKS/Ghp (Fig. 1A) and ligated to a
phosphorylated BamHI adaptor (5*-pACTTCTAGACG- reading frames, the vector/insert junctions were se-
quenced, then the recombinant plasmid was used toGATCCGTCTAGA-3*) generating cohesive ends which
are compatible with the gene’s 5*-end HinfI site and transform E. coli BL21. Lysates of cells induced with IPTG
were analyzed by Western blotting using a commerciallywhich allowed the in-frame insertion of the coding se-
quence to that of the T7-Tag coding region of pET21b. available anti-T7-Tag monoclonal antibody (MAb). The
antibody specifically reacted with a protein of 50 kDaThe resulting DNA fragment was digested with BamHI
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manner an antiserum which specifically recognized a 50-
kDa protein within E. coli extracts harboring pET/BICP27
(Fig. 2A, lane 4) but not pET21b (lane 3) was obtained.
This antiserum also specifically reacted with a protein
of 49 kDa within extracts of COS cells transfected with
a eukaryotic expression vector (pcDNA3/BICP27) con-
taining the BICP27 coding sequence but not in that from
cells transfected with only the vector (results not shown).
The difference in the molecular masses of the protein
observed following expression in E. coli as compared to
that in COS cells is ascribed to the absence of the T7-
Tag protein domain in the latter case.
The expression kinetics of the BICP27 protein in BHV-
1-infected cells were investigated by Western blot analy-
ses of total proteins extracted at different times postinfec-
tion (Fig. 2B). The BICP27-specific antiserum did not react
with any protein before 3 hr p.i. (results not shown). As
of 3 hr p.i., a 49-kDa protein whose abundance increased
21-fold 15 hr p.i. was detected. After this time point a
progressive decrease in the levels of this protein was
observed up to 24 hr following infection. The observed
molecular mass of the BICP27 protein correlates well
with that reported (50 kDa; 13) using an antiserum di-
rected against a synthetic peptide derived from the de-
duced amino acid sequence of the BICP27 ORF. The
FIG. 2. Expression kinetics of the BICP27 protein. (A) Western blot expression profile observed is consistent with that ob-
analyses of E. coli extracts derived from cells harboring either pET21b tained at the transcript level and correlates with that
(lanes 1 and 3) or pET/BICP27 (lanes 2 and 4). Recombinant E. coli of a protein expressed early following BHV-1 infection.
BL21 cells were cultured to an O.D.600nm of 0.6 at room temperature
Worthwhile to mention, the BICP27 antiserum did notwithout agitation in terrific broth (24) containing 50 mg/ml ampicillin
react with any protein from purified BHV-1 (not shown),and 200 mg/ml arginine and then induced with 0.4 mM IPTG for 2 days.
Cells were collected, resuspended in 0.1 vol of TEN (10 mM Tris–HCl, indicating that BICP27 does not constitute a structural
pH 7.5, 1 mM EDTA, 100 mM NaCl), containing 1 mg/ml lysozyme, and component of the virion.
sonicated. After centrifugation, proteins contained in inclusion bodies Thus in contrast to HSV-1, the transcription and protein
were fractionated by SDS–PAGE and then electrotransferred onto a
expression profiles of BICP27 correlate with that of anPVDF membrane (Bio-Rad). Western blots were performed as de-
early (b) rather than that of an immediate-early (a) gene.scribed (26) using a commercially available anti-T7-Tag MAb (lanes 1
and 2) or an antiserum raised against the T7-Tag/BICP27 fusion protein Furthermore, the expression profiles of the BICP27 pro-
expressed in E. coli (lanes 3 and 4). The numbers to the left correspond tein and of its specific transcript fluctuate in a manner
to molecular masses of standards in kDa. (B) Western blot analysis of which is distinct from that reported for ICP27 (14–16). In
total proteins from BHV-1-infected cells. Confluent monolayers of MDBK
contrast to the expression profiles which are observedcells (18 1 106 total cells) were infected with BHV-1 at an m.o.i. of 2
with ICP27, those of BICP27 extend over a longer periodfor 0, 3, 6, 9, 12, 15, 18, and 24 hr. Cell lysate aliquots of 40 ml, prepared
as previously described (27), were fractionated by SDS–PAGE. Proteins of time. At the transcriptional level, ICP27’s peak abun-
were electrotransferred onto a PVDF membrane and then reacted with dance is reached approximately 5 hr postinfection (16),
the BICP27-specific antiserum. The numbers to the left correspond to whereas that of BICP27 is attained 12 hr following infec-
molecular masses of standards in kDa. At the bottom of the blot is
tion. Subsequent to peak expression, a detectable de-indicated the relative abundance of the BICP27 protein. This was evalu-
crease in the levels of both the ICP27- and BICP27-spe-ated as described in the legend of Fig. 1.
cific transcripts is observed 7 and 20 hr, respectively,
following viral infection. The expression profiles of the
proteins essentially follow that of their transcripts (thisfound within E. coli extracts harboring the recombinant
plasmid (Fig. 2A, lane 2) but not in that derived from study, 14, 15). The difference in the broadness of the two
profiles suggests differences in the function of the twocells harboring only the vector (lane 1). The observed
molecular mass of the polypeptide was within the size proteins.
The expression profile of BICP27 suggests that it isrange expected (45.4 kDa) for the T7-Tag/BICP27 con-
struct, confirming its identity. The T7-Tag/BICP27 fusion needed until fairly late in the infectious cycle. Interest-
ingly, from 3 to 12 hr p.i. the expression profile at theprotein was purified twice by electroelution following pre-
parative SDS–PAGE and then used to immunize mice level of the protein parallels that of the transcript but
the protein’s accumulation was three times that of itsfor the production of a BICP27-specific antiserum. In this
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